From Our Partners
Saturday, June 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Rapid Medical Countermeasure Response to Infectious Diseases

by Global Biodefense Staff
October 19, 2015
BioWatch PCR Biodetection Alternatives

The Institute of Medicine’s Forum on Medical and Public Health Preparedness for Catastrophic Events; Forum on Drug Discovery, Development, and Translation; and Forum on Microbial Threats co-convened a workshop this spring in Washington, DC.

A new summary of the workshop released this week features discussions on the MCM development process in the face of three types of infectious disease outbreaks and explores the regulatory and operational challenges encountered when rapid response is needed for an already evolving worldwide emergency.

Highlighted sections include:

  • A Wake Up Call: The 2014 Ebola Outbreak Response
  • Preparedness as an Issue of National Security
  • Rapid Development of Ebola Vaccines
  • Influenza Risk Assessment and Pandemic Preparedness
  • Developing MCMs for Coronaviruses

Participants at the workshop also examined potential business models for future public-private partnerships and discussed what level of sustainable funding is needed to meet the demands of emerging threats across the globe.

Read the summary: Rapid Medical Countermeasure Response to Infectious Diseases – Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships.

From Our Partners
Tags: BioterrorismBioWatchCoronavirusEbolaInfluenzaMERS-CoV

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC